Qorvo (QRVO) 10-Q 30 Oct 24 2025 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Sep. 28, 2024	Oct. 23, 2024
Cover [Abstract]
Document Transition Report	false
Document Quarterly Report	true
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Current Reporting Status	Yes
Entity Incorporation, State or Country Code	DE
Entity Registrant Name	Qorvo, Inc.
City Area Code	336
Entity Central Index Key	0001604778
Document Type	10-Q
Document Period End Date	Sep. 28, 2024
Entity File Number	001-36801
Amendment Flag	false
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--03-29
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding		94,526,698
Entity Address, Address Line One	7628 Thorndike Road
Local Phone Number	664-1233
Entity Interactive Data Current	Yes
Entity Shell Company	false
Trading Symbol	QRVO
Security Exchange Name	NASDAQ
Entity Tax Identification Number	46-5288992
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27409-9421
Document Fiscal Year Focus	2025

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 28, 2024	Mar. 30, 2024
Current assets:
Cash and cash equivalents	$ 1,096,452	$ 1,029,258
Accounts receivable, net of allowance of $321 and $313 as of September 28, 2024 and March 30, 2024, respectively	580,963	412,960
Inventories	694,457	710,555
Prepaid expenses	37,643	40,563
Other Receivables, Net, Current	12,799	14,427
Other current assets	110,145	78,993
Disposal Group, Including Discontinued Operation, Assets	0	159,278
Total current assets	2,532,459	2,446,034
Property and equipment, net of accumulated depreciation of $1,772,229 and $1,683,592 as of September 28, 2024 and March 30, 2024, respectively	846,540	870,982
Goodwill	2,437,790	2,534,601
Intangible assets, net	445,715	509,383
Long-term investments	24,804	23,252
Other non-current assets	215,767	170,383
Total assets	6,503,075	6,554,635
Current liabilities:
Accounts payable	321,880	252,993
Accrued liabilities	353,701	336,767
Long-term Debt, Current Maturities	412,179	438,740
Other current liabilities	245,977	113,215
Disposal Group, Including Discontinued Operation, Liabilities	0	88,372
Total current liabilities	1,333,737	1,230,087
Long-Term Debt, Excluding Current Maturities	1,549,244	1,549,272
Other long-term liabilities	209,925	218,904
Total liabilities	3,092,906	2,998,263
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 94,664 and 95,798 shares issued and outstanding at September 28, 2024 and March 30, 2024, respectively	3,515,640	3,651,067
Accumulated other comprehensive income (loss)	1,148	(5,097)
Accumulated deficit	(106,619)	(89,598)
Total stockholders’ equity	3,410,169	3,556,372
Total liabilities and stockholders’ equity	$ 6,503,075	$ 6,554,635

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 28, 2024	Mar. 30, 2024
Statement of Financial Position [Abstract]
Common stock, shares outstanding	94,664,000	95,798,000
Accounts Receivable, Allowance for Credit Loss, Current	$ 321	$ 313
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 1,772,229	$ 1,683,592
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, par value	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	405,000,000	405,000,000
Common Stock, Shares, Issued	94,664,000	95,798,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues	$ 1,046,509	$ 1,103,493	$ 1,933,180	$ 1,754,657
Cost of goods sold	601,203	613,803	1,155,570	1,035,897
Gross profit	445,306	489,690	777,610	718,760
Operating Expenses [Abstract]
Research and Development Expense	201,050	174,947	388,652	338,037
Selling, general and administrative	107,760	103,696	222,683	209,119
Goodwill, Impairment Loss	96,458	48,000	96,458	48,000
Other operating expense	30,363	11,619	55,536	20,312
Total operating expenses	435,631	338,262	763,329	615,468
Operating Income (Loss), Total	9,675	151,428	14,281	103,292
Interest expense	(22,594)	(17,121)	(39,688)	(34,382)
Other income, net	15,422	5,211	27,187	18,927
Income before income taxes	2,503	139,518	1,780	87,837
Income tax benefit	(19,938)	(42,057)	(18,801)	(33,956)
Net income	$ (17,435)	$ 97,461	$ (17,021)	$ 53,881
Earnings Per Share [Abstract]
Basic	$ (0.18)	$ 1	$ (0.18)	$ 0.55
Diluted	$ (0.18)	$ 0.99	$ (0.18)	$ 0.54
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic	94,886	97,945	95,116	98,167
Diluted	94,886	98,590	95,116	98,892

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ (17,435)	$ 97,461	$ (17,021)	$ 53,881
Other comprehensive income (loss), net of tax:
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax	(230)	0	(230)	0
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature	7,408	(9,569)	6,476	(10,428)
Reclassification adjustments, net of tax:
Amortization of pension actuarial gain	(1)	(3)	(1)	(6)
Other comprehensive income (loss)	7,177	(9,572)	6,245	(10,434)
Total comprehensive (loss) income	$ (10,258)	$ 87,889	$ (10,776)	$ 43,447

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive Loss	Retained Earnings [Member]
Common Stock, Shares, Outstanding		98,649
Common stock and additional paid-in capital	$ 3,821,474
Stockholders' Equity Attributable to Parent	3,902,794
Accumulated Other Comprehensive Income (Loss), Net of Tax	(3,175)
Retained Earnings (Accumulated Deficit)	84,495
Net (loss) income	53,881	$ 0	$ 0	$ 53,881
Other Comprehensive Income (Loss), Net of Tax	(10,434)	$ 0	(10,434)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		597
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(24,163)	$ (24,163)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		262
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 19,180	$ 19,180	0	0
Stock Repurchased During Period, Shares	(2,000)	(2,002)
Stock Repurchased During Period, Value	$ (201,166)	$ (97,396)	0	(103,770)
Stock-based compensation	77,094	$ 77,094	0	0
Payments for Repurchase of Common Stock	200,026
Common Stock, Shares, Outstanding		98,048
Common stock and additional paid-in capital	3,816,260
Stockholders' Equity Attributable to Parent	3,812,223
Accumulated Other Comprehensive Income (Loss), Net of Tax	(4,037)
Retained Earnings (Accumulated Deficit)	0
Net (loss) income	97,461	$ 0	0	97,461
Other Comprehensive Income (Loss), Net of Tax	(9,572)	$ 0	(9,572)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		427
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	$ (19,741)	$ (19,741)	0	0
Stock Repurchased During Period, Shares	(1,000)	(969)
Stock Repurchased During Period, Value	$ (100,554)	$ (37,699)	0	(62,855)
Stock-based compensation	37,369	$ 37,369	0	0
Common Stock, Shares, Outstanding		97,506
Common stock and additional paid-in capital	3,796,189
Stockholders' Equity Attributable to Parent	3,817,186
Accumulated Other Comprehensive Income (Loss), Net of Tax	(13,609)
Retained Earnings (Accumulated Deficit)	$ 34,606
Common Stock, Shares, Outstanding	95,798
Common stock and additional paid-in capital	$ 3,651,067
Stockholders' Equity Attributable to Parent	3,556,372
Accumulated Other Comprehensive Income (Loss), Net of Tax	(5,097)
Retained Earnings (Accumulated Deficit)	(89,598)
Net (loss) income	(17,021)	$ 0	0	(17,021)
Other Comprehensive Income (Loss), Net of Tax	6,245	$ 0	6,245	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		577
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(29,521)	$ (29,521)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		266
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 19,787	$ 19,787	0	0
Stock Repurchased During Period, Shares	(2,000)	(1,977)
Stock Repurchased During Period, Value	$ (207,471)	$ (207,471)	0	0
Stock-based compensation	81,778	$ 81,778	0	0
Payments for Repurchase of Common Stock	206,340
Common Stock, Shares, Outstanding		94,962
Common stock and additional paid-in capital	3,581,468
Stockholders' Equity Attributable to Parent	3,486,255
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,029)
Retained Earnings (Accumulated Deficit)	(89,184)
Net (loss) income	(17,435)	$ 0	0	(17,435)
Other Comprehensive Income (Loss), Net of Tax	7,177	$ 0	7,177	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		440
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	$ (22,256)	$ (22,256)	0	0
Stock Repurchased During Period, Shares	(700)	(738)
Stock Repurchased During Period, Value	$ (81,746)	$ (81,746)	0	0
Stock-based compensation	$ 38,174	$ 38,174	$ 0	$ 0
Common Stock, Shares, Outstanding	94,664	94,664
Common stock and additional paid-in capital	$ 3,515,640
Stockholders' Equity Attributable to Parent	3,410,169
Accumulated Other Comprehensive Income (Loss), Net of Tax	1,148
Retained Earnings (Accumulated Deficit)	$ (106,619)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net (loss) income	$ (17,021)	$ 53,881
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation	81,567	99,183
Intangible assets amortization	70,664	61,103
Deferred income taxes	(47,453)	1,629
Goodwill, Impairment Loss	96,458	48,000
Stock-based compensation expense	80,547	77,498
Other, net	50,979	16,377
Changes in operating assets and liabilities:
Accounts receivable, net	(168,213)	(288,221)
Inventories	2,550	(45,694)
Prepaid expenses and other assets	(22,036)	(2,547)
Accounts payable and accrued liabilities	83,631	148,616
Income taxes payable and receivable	(6,734)	(9,674)
Other liabilities	3,992	(22,253)
Net cash provided by operating activities	208,931	137,898
Cash flows from investing activities:
Purchase of property and equipment	(71,244)	(68,076)
Proceeds from Sale of Property, Plant, and Equipment	1,414	47,301
Proceeds from Divestiture of Businesses	55,576	0
Other investing activities	(37,756)	(3,418)
Net cash used in investing activities	(52,010)	(24,193)
Cash flows from financing activities:
Repurchase of common stock, including transaction costs	(206,340)	(200,026)
Proceeds from the issuance of common stock	21,057	21,041
Tax withholding paid on behalf of employees for restricted stock units	(29,551)	(25,472)
Repayments of Debt	26,661	0
Purchase and supply commitment, Supplies Proceeds	142,804	0
Other financing activities	(10,565)	(9,854)
Net cash used in financing activities	(109,256)	(214,311)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(471)	(1,501)
Net increase (decrease) in cash, cash equivalents and restricted cash	47,194	(102,107)
Cash, cash equivalents and restricted cash at the beginning of the period	1,049,258	808,943
Cash, cash equivalents and restricted cash at the end of the period	1,096,452	706,836
Capital expenditures included in liabilities	$ 73,031	$ 27,610

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	6 Months Ended
	Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	The accompanying Condensed Consolidated Financial Statements of Qorvo, Inc. and Subsidiaries (together, the "Company" or "Qorvo") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). The preparation of these financial statements requires management to make estimates and assumptions, which could differ materially from actual results. In addition, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the SEC. In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. These Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended March 30, 2024. The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company is organized into three operating and reportable segments that align technologies and applications with customers and end markets: High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG"). Certain prior period amounts have been reclassified to conform to the fiscal 2025 presentation. The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. Each fiscal year, the first quarter ends on the Saturday closest to June 30, the second quarter ends on the Saturday closest to September 30 and the third quarter ends on the Saturday closest to December 31. Fiscal years 2025 and 2024 are 52-week years.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Sep. 28, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
Accounting Standards Update and Change in Accounting Principle [Text Block]	In August 2022, the Creating Helpful Incentives to Produce Semiconductors and Science Act (the "CHIPS Act") was signed into law. The CHIPS Act provides for a 25% refundable tax credit on certain investments in domestic semiconductor manufacturing. The tax credit is provided for qualifying property and equipment which is placed in service after December 31, 2022, and for which construction begins before January 1, 2027. The CHIPS Act also provides for certain other financial incentives to further investments in domestic semiconductor manufacturing. During the three months ended September 28, 2024, the Company recognized an anticipated tax credit within other non-current assets related to qualifying expenditures placed in service since December 31, 2022 (which will be amortized over the useful lives of the qualifying assets), with a corresponding reduction to the carrying amount of the qualifying property and equipment. In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update 2023-07, " Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures " ("ASU 2023-07"), which requires enhanced disclosures related to significant segment expenses. The Company will adopt ASU 2023-07 for its fiscal 2025 annual report and for interim periods beginning in fiscal 2026 on a retrospective basis. The Company is currently evaluating the effect this new standard will have on its disclosures.

Inventories

Inventories	6 Months Ended
	Sep. 28, 2024
Inventory Disclosure [Abstract]
INVENTORIES	The components of inventories, net of reserves, are as follows (in thousands): September 28, 2024 March 30, 2024 Raw materials $ 217,105 $ 201,748 Work in process 322,092 347,175 Finished goods 155,260 161,632 Total inventories $ 694,457 $ 710,555

Business Divestiture

Business Divestiture	3 Months Ended
	Sep. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure	On December 16, 2023, the Company entered into a definitive agreement (the "Purchase Agreement") with Luxshare Precision Industry Co., Ltd. ("Luxshare") to divest its assembly and test operations in Beijing and Dezhou, China (the "Disposal Group") for preliminary cash proceeds of approximately $240.0 million (for the cash on hand of the disposed business, the assets and liabilities of the Disposal Group and inventory). In the fourth quarter of fiscal 2024, regulatory approvals were received, and the Disposal Group met the criteria to be classified as held for sale in accordance with Accounting Standards Codification ("ASC") 360, " Property, Plant and Equipment " ("ASC 360"). In accordance with ASC 805, " Business Combinations, " the Disposal Group constituted a business, and therefore, the Company allocated $22.0 million of goodwill from three of its reporting units to assets held for sale based on a relative fair value basis. These reporting units were evaluated for impairment subsequent to the allocation of goodwill to the Disposal Group and it was determined that the fair value of all reporting units was in excess of their carrying amounts. Additionally, in accordance with ASC 360, the Disposal Group was measured at the lower of carrying value or fair value less costs to sell. As the carrying value of the Disposal Group exceeded the fair value less costs to sell, a loss of $35.3 million was recognized for the year ended March 30, 2024, which was recorded in "Other operating expense" in the Consolidated Statement of Operations. The divestiture of the Disposal Group did not meet the criteria to be reported as discontinued operations per ASC 205-20, " Presentation of Financial Statements: Discontinued Operations. " The Company completed the sale of its assembly and test operations in China on May 2, 2024 for a purchase price of approximately $232.0 million, resulting in an incremental loss of $8.0 million (which included an ad ditional goodwill write-off of $1.0 million) recorded in "Other operating expense" in the Condensed Consolidated Statement of Operations for the three months ended June 29, 2024 . The consideration received was for the cash on hand of the disposed business of $29.0 million , the assets and liabilities of the Disposal Group of $76.0 million and inventory of $127.0 million . The purchase price, which was subject to certain post-closing adjustments, increased to $234.0 million in the three months ended September 28, 2024 , as a result of a $2.0 million increase in the value of inventory. The inventory amount relates to inventory that the Company sold to Luxshare and is obligated to repurchase at a future date subsequent to the performance of assembly and test services by Luxshare pursuant to a supply agreement. While legal title to the inventory resides with Luxshare, in accordance with ASC 606 " Revenue from Contracts with Customers ," the Company will continue to recognize the inventory on its balance sheet and has recorded a financial liability (which is included in "Other current liabilities") equal to the cash received by the Company attributable to the inventory subject to repurchase. The cash received from the sale of the assets and liabilities of the Disposal Group of $76.0 million is included in cash flows from investing activities in the Condensed Consolidated Statement of Cash Flows for the six months ended September 28, 2024, net of a $20.0 million deposit received in fiscal 2024 upon execution of the Purchase Agreement (which was included in “Other investing activities” in the fiscal 2024 Consolidated Statement of Cash Flows). The cash received for the inventory subject to repurchase by the Company is included in cash flows from financing activities in the Condensed Consolidated Statement of Cash Flows for the six months ended September 28, 2024.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Sep. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	In fiscal 2025, as part of ongoing efforts to focus on growth drivers and key markets and to streamline operations, the Company decided not to further invest in its silicon carbide (“SiC”) power device business and began to seek strategic alternatives for this business. In the second quarter of fiscal 2025, the Company determined that there was a more-likely-than-not expectation of divesting its SiC power device business and impairment testing was triggered. The long-lived assets that are held and used by the power device business were reviewed for impairment in accordance with ASC 360. The impairment testing resulted in the impairment of intangible assets (primarily developed technology) of $16.6 million, which is included in "Other operating expense" in the Condensed Consolidated Statements of Operations. In addition, as the power device business constitutes a reporting unit within the HPA operating segment, the goodwill of the reporting unit was also subject to an impairment assessment in accordance with ASC 350, "Intangibles - Goodwill and Other" ("ASC 350") and it was determined that the carrying value exceeded the fair value of this reporting unit, resulting in a goodwill impairment charge of approximately $96.5 million (representing the entire goodwill assigned to this reporting unit). The estimated fair values of the intangible assets and the reporting unit were determined using a market approach. The significant inputs related to valuing these assets are classified as Level 3 in the fair value hierarchy. Refer to Note 11 for additional charges associated with the Company's decision to seek strategic alternatives for its SiC power device business. The changes in the carrying amount of goodwill are as follows (in thousands): HPA CSG ACG Total Balance as of March 30, 2024 (1) $ 517,542 $ 300,299 $ 1,716,760 $ 2,534,601 Goodwill impairment (96,458) — — (96,458) Goodwill written off related to sale of business (2) — (200) (800) (1,000) Anokiwave, Inc. measurement period adjustments 647 — — 647 Balance as of September 28, 2024 (1) $ 421,731 $ 300,099 $ 1,715,960 $ 2,437,790 (1) The Company’s goodwill balance is presented net of accumulated impairment losses totaling $999.9 million and $903.4 million as of September 28, 2024 and March 30, 2024, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023, 2024 and 2025. (2) Refer to Note 4 for additional information. The following table summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): September 28, 2024 March 30, 2024 Gross Accumulated Gross Accumulated Developed technology $ 819,450 $ 465,031 $ 903,089 $ 484,347 Customer relationships 100,040 76,489 100,040 67,999 Technology licenses 74,625 17,052 54,869 6,525 Trade names 700 146 1,610 939 In-process research and development 9,618 N/A 9,585 N/A Total (1) $ 1,004,433 $ 558,718 $ 1,069,193 $ 559,810 (1) Amounts include the impact of foreign currency translation. At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets.

Investments and Fair Value of F

Investments and Fair Value of Financial Instruments	6 Months Ended
	Sep. 28, 2024
Investments and Fair Value Measurements [Abstract]
Investments and Fair Value Measurements [Text Block]	Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments and are considered Level 1 in the fair value hierarchy. The fair value of the mutual funds as of September 28, 2024 and March 30, 2024 was $58.5 million and $52.3 million

Long-Term Debt

Long-Term Debt	6 Months Ended
	Sep. 28, 2024
Debt Disclosure [Abstract]
DEBT	The following table summarizes the outstanding debt (in thousands): September 28, 2024 March 30, 2024 1.750% senior notes due 2024 $ 412,463 $ 439,738 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Unamortized premium, discount and issuance costs, net (1,040) (1,726) Total debt 1,961,423 1,988,012 Less current portion of debt (412,179) (438,740) Total long-term debt $ 1,549,244 $ 1,549,272 Credit Agreement On April 23, 2024, the Company entered into a five-year unsecured senior credit facility pursuant to a credit agreement with Bank of America, N.A., as administrative agent, swing line lender and letter of credit issuer and a syndicate of lenders (the "Credit Agreement"), which replaced the previous credit agreement dated as of September 29, 2020. The Credit Agreement provides for a $325.0 million senior revolving line of credit (the "Revolving Facility"). Up to $25.0 million of the Revolving Facility may be used for the issuance of standby letters of credit and up to $10.0 million of the Revolving Facility may be used for swing line advances (i.e., short-term borrowings made available from the lead lender). The Company may request at any time that the Revolving Facility be increased by up to $325.0 million , subject to securing additional funding commitments from existing or new lenders. The Revolving Facility is available to finance working capital, capital expenditures and other lawful corporate purposes. The initial maturity date of the Revolving Facility is April 23, 2029, which may be extended by up to two years by exercising extension options provided in the Credit Agreement. At the Company’s option, loans under the Credit Agreement bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus Term SOFR (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate of Bank of America, N.A., or (c) Term SOFR plus 1.00% (the “Base Rate”). All swing line loans bear interest at a rate equal to the Applicable Rate plus the Base Rate. Term SOFR is the rate per annum equal to the forward-looking SOFR term rate for interest periods of one, three or six months, as selected by the Company, plus an adjustment of 0.10%. The Applicable Rate is determined by reference to a pricing grid based on the Consolidated Leverage Ratio (as defined in the Credit Agreement) or, at the option of the Company, the Debt Rating (as defined in the Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.750% per annum and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.750% per annum. Undrawn amounts under the Revolving Facility are subject to a commitment fee ranging from 0.125% to 0.275%. Interest for Term SOFR loans is payable at the end of each applicable interest period or at three-month intervals, if such interest period exceeds three months. Interest for Base Rate loans is payable quarterly in arrears. The Company pays a letter of credit fee equal to the Applicable Rate multiplied by the daily amount available to be drawn under any letter of credit, a fronting fee and any customary documentary and processing charges for any letter of credit issued under the Credit Agreement. During the six months ended September 28, 2024, there were no borrowings under the Revolving Facility. The Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and avoid an event of default. As of September 28, 2024, the Company was in compliance with these covenants. Senior Notes due 2024 On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by certain of the Company's U.S. subsidiaries (the "Guarantors"). The 2024 Notes were issued pursuant to an indenture, dated as of December 14, 2021 (the "2021 Indenture"), by and among the Company, the Guarantors and Computershare Trust Company, N.A., as trustee. The 2021 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants. In fiscal 2024, the Company repurchased $60.3 million of the principal amount of the 2024 Notes, plus accrued and unpaid interest, on the open market. In the first quarter of fiscal 2025, the Company repurchased $27.3 million of the principal amount of the 2024 Notes, plus accrued and unpaid interest, on the open market, and the Company recognized a net gain on debt extinguishment of $0.6 million, which is included in "Other income, net" in the Condensed Consolidated Statement of Operations. The remaining principal amount of the 2024 Notes of $412.5 million and $439.7 million is included in "Current portion of long-term debt" in the Condensed Consolidated Balance Sheets as of September 28, 2024 and March 30, 2024, respectively. Interest is payable on the 2024 Notes on June 15 and December 15 of each year. The Company paid interest of $3.6 million and $4.4 million on the 2024 Notes during the six months ended September 28, 2024 and September 30, 2023, respectively. Senior Notes due 2029 On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and collectively with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019, and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture. Interest is payable on the 2029 Notes on April 15 and October 15 of each year. The Company paid interest of $18.6 million on the 2029 Notes during the six months ended September 28, 2024 and September 30, 2023. Senior Notes due 2031 On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture. Interest is payable on the 2031 Notes on April 1 and October 1 of each year. The Company paid interest of $11.8 million on the 2031 Notes during the six months ended September 28, 2024, and paid no interest during the six months ended September 30, 2023 (interest was subsequently paid on October 2, 2023). Fair Value of Debt The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of September 28, 2024 was $409.0 million, $824.5 million and $626.8 million, respectively (compared to the outstanding principal amount of $412.5 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of March 30, 2024 was $426.9 million, $797.6 million and $603.8 million, respectively (compared to the outstanding principal amount of $439.7 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period. Interest Expense During the three and six months ended September 28, 2024, the Company recognized $24.3 million and $42.0 million of interest expense , respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, which was partially offset by interest capitalized to property and equipment of $1.7 million and $2.3 million, respectively. Interest expense for the three and six months ended September 28, 2024 also includes financing costs related to certain inventory (subject to repurchase) in connection with a supply agreement. During the three and six months ended September 30, 2023, the Company recognized $17.9 million and $36.1 million of interest expense, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, which was partially offset by interest capitalized to property and equipment of $0.8 million and $1.7 million, respectively.

Stock Repurchases

Stock Repurchases	6 Months Ended
	Sep. 28, 2024
Equity [Abstract]
STOCK REPURCHASES	On November 2, 2022, the Company announced that its Board of Directors authorized a share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization. Under this program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice. During the three and six months ended September 28, 2024, the Company repurchased approximately 0.7 million and 2.0 million shares of its common stock, respectively, for approximately $81.7 million and $207.5 million, respectively (including transaction costs and excise tax) and approximately $1,098.7 million remains authorized for repurchases under its share repurchase program as of September 28, 2024. During the three and six months ended September 30, 2023, the Company repurchased approximately 1.0 million and 2.0 million shares of its common stock, respectively, for approximately $100.6 million and $201.2 million, respectively (including transaction costs and excise tax) under its share repurchase program.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	6 Months Ended
	Sep. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Legal Matters The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

Revenue

Revenue	6 Months Ended
	Sep. 28, 2024
Revenue from Contract with Customer [Abstract]
REVENUE	Revenue by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands): Three Months Ended Six Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 United States $ 656,610 $ 699,288 $ 1,104,066 $ 1,014,571 China 151,763 189,900 348,197 340,706 Other Asia 113,185 119,395 245,221 210,729 Taiwan 102,298 66,162 194,852 132,018 Europe 22,653 28,748 40,844 56,633 Total revenue $ 1,046,509 $ 1,103,493 $ 1,933,180 $ 1,754,657 The Company also disaggregates revenue by operating segments (refer to Note 12).

Restructuring and Related Activ

Restructuring and Related Activities	6 Months Ended
	Sep. 28, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING	2025 Restructuring Initiative In fiscal 2025, as part of ongoing efforts to focus on growth drivers and key markets and to streamline operations, the Company decided not to further invest in its SiC power device business and began to seek strategic alternatives for this business (the “2025 Restructuring Initiative”). In the second quarter of fiscal 2025, the Company determined that there was a more-likely-than-not expectation of divesting its SiC power device business and impairment testing was triggered. The inventory and long-lived assets that are held and used by the power device business were reviewed for impairment in accordance with ASC 330, " Inventory " and ASC 360, respectively, resulting in inventory write-downs of $13.7 million (for inventory expected to be disposed of) and impairments of intangible assets (primarily developed technology) of $16.6 million. In addition, as the power device business constitutes a reporting unit, the goodwill of the reporting unit was also subject to an impairment assessment in accordance with ASC 350 and it was determined that the carrying value exceeded the fair value of this reporting unit, resulting in a goodwill impairment charge of approximately $96.5 million (representing the entire goodwill assigned to this reporting unit). The following table summarizes charges resulting from the 2025 Restructuring Initiative (in thousands): Three Months Ended September 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ — $ — $ 2,649 $ 2,649 Asset impairment costs 13,660 96,458 16,766 126,884 Total $ 13,660 $ 96,458 $ 19,415 $ 129,533 Six Months Ended September 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ — $ — $ 3,048 $ 3,048 Asset impairment costs 13,660 96,458 16,766 126,884 Total $ 13,660 $ 96,458 $ 19,814 $ 129,932 The following table summarizes the liability activity related to the 2025 Restructuring Initiative for the six months ended September 28, 2024 (in thousands): Contract Termination and Other Costs Accrued restructuring balance as of March 30, 2024 $ — Costs incurred and charged to expense 3,048 Cash payments (3,048) Accrued restructuring balance as of September 28, 2024 $ — 2024 Restructuring Initiative In the third quarter of fiscal 2024 the Company entered into a definitive agreement with Luxshare to divest its assembly and test operations in Beijing and Dezhou, China. The sale of these operations (the "2024 Restructuring Initiative") was completed in the first quarter of fiscal 2025 (refer to Note 4 for additional information). The following table summarizes charges resulting from the 2024 Restructuring Initiative (in thousands): Three Months Ended September 28, 2024 Six Months Ended September 28, 2024 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ — $ 643 $ 643 $ — $ 3,995 $ 3,995 Asset impairment costs (adjustments) (1) 1,754 (2,358) (604) 1,754 5,718 7,472 One-time employee termination benefits — 386 386 — 5,712 5,712 Total $ 1,754 $ (1,329) $ 425 $ 1,754 $ 15,425 $ 17,179 (1) Refer to Note 4 for additional information. As of September 28, 2024, the Company has recorded cumulative expenses of approximately $11.2 million, $44.4 million and $14.6 million for contract termination and other costs, asset impairment costs, and one-time employee termination benefits, respectively, as a result of the 2024 Restructuring Initiative. The Company does not expect to incur material additional charges related to the 2024 Restructuring Initiative. The following table summarizes the liability activity related to the 2024 Restructuring Initiative for the six months ended September 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 7,432 $ 4,080 $ 11,512 Costs incurred and charged to expense 5,712 3,995 9,707 Cash payments (12,512) (7,355) (19,867) Accrued restructuring balance as of September 28, 2024 $ 632 $ 720 $ 1,352 2023 Restructuring Initiatives During fiscal 2023, the Company initiated actions to improve efficiencies in its operations and further align the organization with its strategic objectives, which primarily included seeking strategic alternatives related to its biotechnology business (the "2023 Restructuring Initiatives"). The Company completed the sale of its biotechnology business in the third quarter of fiscal 2024. The following tables summarize the charges resulting from the 2023 Restructuring Initiatives (in thousands): Three Months Ended September 28, 2024 Six Months Ended September 28, 2024 Other Operating Expense Other Operating Expense Contract termination and other costs $ 92 $ 186 One-time employee termination benefits — 321 Total $ 92 $ 507 Three Months Ended September 30, 2023 Six Months Ended September 30, 2023 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 2,482 $ 1,328 $ 3,810 $ 19,278 $ 2,757 $ 22,035 Asset impairment costs — 3,646 3,646 2,159 4,286 6,445 One-time employee termination benefits — 962 962 — 2,674 2,674 Total $ 2,482 $ 5,936 $ 8,418 $ 21,437 $ 9,717 $ 31,154 As of September 28, 2024, the Company has recorded cumulative expenses of approximately $46.2 million, $99.9 million, $12.4 million and $5.9 million for contract termination and other costs, asset impairment costs, goodwill impairment charges, and one-time employee termination benefits, respectively, as a result of the 2023 Restructuring Initiatives. The Company does not expect to incur material additional charges related to the 2023 Restructuring Initiatives. The following table summarizes the liability activity related to the 2023 Restructuring Initiatives for the six months ended September 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 347 $ 9,308 $ 9,655 Costs incurred and charged to expense 321 186 507 Cash payments (668) (9,402) (10,070) Accrued restructuring balance as of September 28, 2024 $ — $ 92 $ 92 The accrued restructuring balances as of September 28, 2024 represent estimated future cash payments required to satisfy the Company's remaining obligations, the majority of which are expected to be paid in the next twelve months. In fiscal 2025, the Company incurred immaterial legal fees and other costs, recorded to "Other operating expense" in connection with other miscellaneous restructuring initiatives.

Operating Segment Information

Operating Segment Information	6 Months Ended
	Sep. 28, 2024
Segment Reporting [Abstract]
OPERATING SEGMENT INFORMATION	The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. The Company’s manufacturing facilities service and provide benefit to all three operating segments and the operating costs of the facilities are reflected in the cost of goods sold for each operating segment. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. The CODM does not evaluate operating segments using discrete asset information. HPA is a leading global supplier of radio frequency ("RF"), analog mixed signal and power management solutions. HPA leverages a diverse portfolio of differentiated process technologies and products to serve customers in automotive, consumer, defense and aerospace, infrastructure, industrial and enterprise, and mobile markets. CSG is a leading global supplier of connectivity and sensor solutions. CSG leverages broad expertise spanning ultra-wideband, Matter ® , Bluetooth ® Low Energy, Zigbee ® , Thread ® , Wi-Fi ® , cellular Internet of Things, and microelectromechanical force sensing touch sensors to serve customers in automotive, consumer, industrial and enterprise, and mobile markets. ACG is a leading global supplier of advanced cellular RF solutions for smartphones and consumer devices including tablets and wearables. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high-performance discrete and highly integrated cellular products. The "All other" category includes operating expenses such as stock-based compensation expense, amortization of acquired intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill and other asset impairments, gain or loss on assets, costs associated with upgrading the Company's core business systems and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole. The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Three Months Ended Six Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Revenue: HPA $ 148,251 $ 149,804 $ 277,719 $ 289,496 CSG 146,822 103,622 261,675 202,885 ACG 751,436 850,067 1,393,786 1,262,276 Total revenue $ 1,046,509 $ 1,103,493 $ 1,933,180 $ 1,754,657 Operating income (loss): HPA $ 13,066 $ 25,446 $ 17,947 $ 49,410 CSG (8,974) (27,725) (28,475) (47,886) ACG 215,057 284,805 331,506 329,803 All other (209,474) (131,098) (306,697) (228,035) Operating income 9,675 151,428 14,281 103,292 Interest expense (22,594) (17,121) (39,688) (34,382) Other income, net 15,422 5,211 27,187 18,927 Income before income taxes $ 2,503 $ 139,518 $ 1,780 $ 87,837 Three Months Ended Six Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Reconciliation of "All other" category: Stock-based compensation expense $ (38,181) $ (39,053) $ (80,547) $ (77,498) Amortization of intangible assets (29,482) (29,963) (59,956) (60,835) Restructuring-related charges (1) (34,396) (8,418) (53,970) (31,154) Acquisition and integration-related costs (1,211) (852) (3,793) (2,047) Goodwill impairment (2) (96,458) (48,000) (96,458) (48,000) Other (9,746) (4,812) (11,973) (8,501) Loss from operations for "All other" $ (209,474) $ (131,098) $ (306,697) $ (228,035) (1) Refer to Note 11 for additional information. (2) Refer to Note 5 for additional information.

Income Taxes

Income Taxes	6 Months Ended
	Sep. 28, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	The Company’s income tax expense was $19.9 million and $18.8 million for the three and six months ended September 28, 2024, respectively, and $42.1 million and $34.0 million for the three and six months ended September 30, 2023, respectively. The Company’s effective tax rate was 796.5% and 1,056.4% for the three and six months ended September 28, 2024, respectively, and 30.1% and 38.7% for the three and six months ended September 30, 2023, respectively. The Company's effective tax rate for the three and six months ended September 28, 2024 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, Global Intangible Low-Taxed Income ("GILTI"), domestic tax credits generated, discrete pretax items (including a non-deductible goodwill impairment charge) and discrete tax items. After consideration of pretax items taxed discretely in the period, the Company recognized tax expense associated with its ongoing operations and the year-to-date income, which was partially offset by discrete tax benefits of $4.3 million and discrete tax expense of $0.2 million for the three and six months ended September 28, 2024, respectively. The discrete tax benefit for the three months ended September 28, 2024 primarily related to the tax impacts of the 2025 Restructuring Initiative (refer to Note 11 for additional information). For the six months ended September 28, 2024, this tax benefit was offset by the tax effects of the sale of the Company's assembly and test operations in China (refer to Note 4 for additional information).

Net Income Per Share

Net Income Per Share	6 Months Ended
	Sep. 28, 2024
Earnings Per Share [Abstract]
NET INCOME PER SHARE	The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data): Three Months Ended Six Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Numerator: Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders $ (17,435) $ 97,461 $ (17,021) $ 53,881 Denominator: Denominator for basic net (loss) income per share — weighted-average shares 94,886 97,945 95,116 98,167 Effect of dilutive securities: Stock-based awards — 645 — 725 Denominator for diluted net (loss) income per share — adjusted weighted-average shares and assumed conversions 94,886 98,590 95,116 98,892 Basic net (loss) income per share $ (0.18) $ 1.00 $ (0.18) $ 0.55 Diluted net (loss) income per share $ (0.18) $ 0.99 $ (0.18) $ 0.54

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ (17,435)	$ 97,461	$ (17,021)	$ 53,881

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 28, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	OTHER INFORMATION. Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements The following table describes actions by our directors or Section 16 officers with respect to plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) during the second quarter of fiscal 2025. None of our directors or Section 16 officers took actions with respect to a "non-Rule 10b5-1 trading arrangement," as such term is defined in Item 408(c) of Regulation S-K, during the second quarter of fiscal 2025. Name and Title Action Date Expiration of Plan Number of Shares to be Sold (1) Frank P. Stewart Senior Vice President and President of Advanced Cellular Adoption 8/5/2024 10/2/2025 2,309 Philip J. Chesley Senior Vice President and President of High Performance Analog Adoption 8/5/2024 8/29/2025 24,357
Frank Stewart [Member]
Trading Arrangements, by Individual
Name	Frank P. Stewart
Title	Senior Vice President and President of Advanced Cellular
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	8/5/2024
Aggregate Available	2,309
Philip Chesley [Member]
Trading Arrangements, by Individual
Name	Philip J. Chesley
Title	Senior Vice President and President of High Performance Analog
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	8/5/2024
Aggregate Available	24,357

Long-Term Debt Fair Value of De

Long-Term Debt Fair Value of Debt (Policies)	6 Months Ended
	Sep. 28, 2024
Debt Disclosure [Abstract]
Fair value of debt [Policy Text Block]	The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of September 28, 2024 was $409.0 million, $824.5 million and $626.8 million, respectively (compared to the outstanding principal amount of $412.5 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of March 30, 2024 was $426.9 million, $797.6 million and $603.8 million, respectively (compared to the outstanding principal amount of $439.7 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

Operating Segment Information S

Operating Segment Information Segment Policy (Policies)	6 Months Ended
	Sep. 28, 2024
Segment Reporting [Abstract]
Segment Reporting, Policy [Policy Text Block]	The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. The Company’s manufacturing facilities service and provide benefit to all three operating segments and the operating costs of the facilities are reflected in the cost of goods sold for each operating segment. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. The CODM does not evaluate operating segments using discrete asset information. HPA is a leading global supplier of radio frequency ("RF"), analog mixed signal and power management solutions. HPA leverages a diverse portfolio of differentiated process technologies and products to serve customers in automotive, consumer, defense and aerospace, infrastructure, industrial and enterprise, and mobile markets. CSG is a leading global supplier of connectivity and sensor solutions. CSG leverages broad expertise spanning ultra-wideband, Matter ® , Bluetooth ® Low Energy, Zigbee ® , Thread ® , Wi-Fi ® , cellular Internet of Things, and microelectromechanical force sensing touch sensors to serve customers in automotive, consumer, industrial and enterprise, and mobile markets. ACG is a leading global supplier of advanced cellular RF solutions for smartphones and consumer devices including tablets and wearables. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high-performance discrete and highly integrated cellular products. The "All other" category includes operating expenses such as stock-based compensation expense, amortization of acquired intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill and other asset impairments, gain or loss on assets, costs associated with upgrading the Company's core business systems and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Sep. 28, 2024
Inventory Disclosure [Abstract]
Components of inventories	The components of inventories, net of reserves, are as follows (in thousands): September 28, 2024 March 30, 2024 Raw materials $ 217,105 $ 201,748 Work in process 322,092 347,175 Finished goods 155,260 161,632 Total inventories $ 694,457 $ 710,555

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Sep. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	The changes in the carrying amount of goodwill are as follows (in thousands): HPA CSG ACG Total Balance as of March 30, 2024 (1) $ 517,542 $ 300,299 $ 1,716,760 $ 2,534,601 Goodwill impairment (96,458) — — (96,458) Goodwill written off related to sale of business (2) — (200) (800) (1,000) Anokiwave, Inc. measurement period adjustments 647 — — 647 Balance as of September 28, 2024 (1) $ 421,731 $ 300,099 $ 1,715,960 $ 2,437,790 (1) The Company’s goodwill balance is presented net of accumulated impairment losses totaling $999.9 million and $903.4 million as of September 28, 2024 and March 30, 2024, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023, 2024 and 2025. (2) Refer to Note 4 for additional information.
Schedule of finite-lived and indefinite-lived intangible assets [Table Text Block]	The following table summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): September 28, 2024 March 30, 2024 Gross Accumulated Gross Accumulated Developed technology $ 819,450 $ 465,031 $ 903,089 $ 484,347 Customer relationships 100,040 76,489 100,040 67,999 Technology licenses 74,625 17,052 54,869 6,525 Trade names 700 146 1,610 939 In-process research and development 9,618 N/A 9,585 N/A Total (1) $ 1,004,433 $ 558,718 $ 1,069,193 $ 559,810 (1) Amounts include the impact of foreign currency translation.

Debt (Tables)

Debt (Tables)	6 Months Ended
	Sep. 28, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the outstanding debt (in thousands): September 28, 2024 March 30, 2024 1.750% senior notes due 2024 $ 412,463 $ 439,738 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Unamortized premium, discount and issuance costs, net (1,040) (1,726) Total debt 1,961,423 1,988,012 Less current portion of debt (412,179) (438,740) Total long-term debt $ 1,549,244 $ 1,549,272

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Sep. 28, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Revenue by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands): Three Months Ended Six Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 United States $ 656,610 $ 699,288 $ 1,104,066 $ 1,014,571 China 151,763 189,900 348,197 340,706 Other Asia 113,185 119,395 245,221 210,729 Taiwan 102,298 66,162 194,852 132,018 Europe 22,653 28,748 40,844 56,633 Total revenue $ 1,046,509 $ 1,103,493 $ 1,933,180 $ 1,754,657

Restructuring and Related Act_2

Restructuring and Related Activities (Tables)	3 Months Ended	6 Months Ended
	Sep. 28, 2024	Sep. 28, 2024
Restructuring and Related Activities [Abstract]
Schedule of restructuring activity		The following table summarizes charges resulting from the 2025 Restructuring Initiative (in thousands): Three Months Ended September 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ — $ — $ 2,649 $ 2,649 Asset impairment costs 13,660 96,458 16,766 126,884 Total $ 13,660 $ 96,458 $ 19,415 $ 129,533 Six Months Ended September 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ — $ — $ 3,048 $ 3,048 Asset impairment costs 13,660 96,458 16,766 126,884 Total $ 13,660 $ 96,458 $ 19,814 $ 129,932 The following table summarizes charges resulting from the 2024 Restructuring Initiative (in thousands): Three Months Ended September 28, 2024 Six Months Ended September 28, 2024 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ — $ 643 $ 643 $ — $ 3,995 $ 3,995 Asset impairment costs (adjustments) (1) 1,754 (2,358) (604) 1,754 5,718 7,472 One-time employee termination benefits — 386 386 — 5,712 5,712 Total $ 1,754 $ (1,329) $ 425 $ 1,754 $ 15,425 $ 17,179 (1) Refer to Note 4 for additional information. The following tables summarize the charges resulting from the 2023 Restructuring Initiatives (in thousands): Three Months Ended September 28, 2024 Six Months Ended September 28, 2024 Other Operating Expense Other Operating Expense Contract termination and other costs $ 92 $ 186 One-time employee termination benefits — 321 Total $ 92 $ 507 Three Months Ended September 30, 2023 Six Months Ended September 30, 2023 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 2,482 $ 1,328 $ 3,810 $ 19,278 $ 2,757 $ 22,035 Asset impairment costs — 3,646 3,646 2,159 4,286 6,445 One-time employee termination benefits — 962 962 — 2,674 2,674 Total $ 2,482 $ 5,936 $ 8,418 $ 21,437 $ 9,717 $ 31,154
Restructuring Liabilities Rollforward	The following table summarizes the liability activity related to the 2024 Restructuring Initiative for the six months ended September 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 7,432 $ 4,080 $ 11,512 Costs incurred and charged to expense 5,712 3,995 9,707 Cash payments (12,512) (7,355) (19,867) Accrued restructuring balance as of September 28, 2024 $ 632 $ 720 $ 1,352 The following table summarizes the liability activity related to the 2023 Restructuring Initiatives for the six months ended September 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 347 $ 9,308 $ 9,655 Costs incurred and charged to expense 321 186 507 Cash payments (668) (9,402) (10,070) Accrued restructuring balance as of September 28, 2024 $ — $ 92 $ 92	The following table summarizes the liability activity related to the 2025 Restructuring Initiative for the six months ended September 28, 2024 (in thousands): Contract Termination and Other Costs Accrued restructuring balance as of March 30, 2024 $ — Costs incurred and charged to expense 3,048 Cash payments (3,048) Accrued restructuring balance as of September 28, 2024 $ —

Operating Segment Information (

Operating Segment Information (Tables)	6 Months Ended
	Sep. 28, 2024
Segment Reporting [Abstract]
Summary of details of reportable segments	The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Three Months Ended Six Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Revenue: HPA $ 148,251 $ 149,804 $ 277,719 $ 289,496 CSG 146,822 103,622 261,675 202,885 ACG 751,436 850,067 1,393,786 1,262,276 Total revenue $ 1,046,509 $ 1,103,493 $ 1,933,180 $ 1,754,657 Operating income (loss): HPA $ 13,066 $ 25,446 $ 17,947 $ 49,410 CSG (8,974) (27,725) (28,475) (47,886) ACG 215,057 284,805 331,506 329,803 All other (209,474) (131,098) (306,697) (228,035) Operating income 9,675 151,428 14,281 103,292 Interest expense (22,594) (17,121) (39,688) (34,382) Other income, net 15,422 5,211 27,187 18,927 Income before income taxes $ 2,503 $ 139,518 $ 1,780 $ 87,837
Summary of reconciliation of "All other" category	Three Months Ended Six Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Reconciliation of "All other" category: Stock-based compensation expense $ (38,181) $ (39,053) $ (80,547) $ (77,498) Amortization of intangible assets (29,482) (29,963) (59,956) (60,835) Restructuring-related charges (1) (34,396) (8,418) (53,970) (31,154) Acquisition and integration-related costs (1,211) (852) (3,793) (2,047) Goodwill impairment (2) (96,458) (48,000) (96,458) (48,000) Other (9,746) (4,812) (11,973) (8,501) Loss from operations for "All other" $ (209,474) $ (131,098) $ (306,697) $ (228,035) (1) Refer to Note 11 for additional information. (2) Refer to Note 5 for additional information.

Net Income Per Share (Tables)

Net Income Per Share (Tables)	6 Months Ended
	Sep. 28, 2024
Earnings Per Share [Abstract]
Reconciliation of the numerators and denominators in the computation of basic and diluted net loss per share	The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data): Three Months Ended Six Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Numerator: Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders $ (17,435) $ 97,461 $ (17,021) $ 53,881 Denominator: Denominator for basic net (loss) income per share — weighted-average shares 94,886 97,945 95,116 98,167 Effect of dilutive securities: Stock-based awards — 645 — 725 Denominator for diluted net (loss) income per share — adjusted weighted-average shares and assumed conversions 94,886 98,590 95,116 98,892 Basic net (loss) income per share $ (0.18) $ 1.00 $ (0.18) $ 0.55 Diluted net (loss) income per share $ (0.18) $ 0.99 $ (0.18) $ 0.54

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Mar. 30, 2024
Components of inventories
Raw materials	$ 217,105	$ 201,748
Work in process	322,092	347,175
Finished goods	155,260	161,632
Total inventories	$ 694,457	$ 710,555

Business Divestiture (Details)

Business Divestiture (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 28, 2024	Jun. 29, 2024	Mar. 30, 2024	May 02, 2024	Dec. 16, 2023
Discontinued Operations and Disposal Groups [Abstract]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal	$ 2,000	$ 8,000	$ 35,300
Disposal Group, Including Discontinued Operation, Consideration	234,000			$ 232,000	$ 240,000
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Inventory				127,000
Disposal Group, Including Discontinued Operation, Goodwill			22,000
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal	2,000	8,000	35,300
Disposal Group, Including Discontinued Operation, Assets	0		159,278
Disposal Group, Including Discontinued Operation, Consideration	234,000			232,000	$ 240,000
Disposal group, including discontinued operation, Net Assets	$ 76,000
Disposal Group, Including Discontinued Operation, Cash			$ 20,000	$ 29,000
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down		$ 1,000

Business Acquisition Narrative

Business Acquisition Narrative (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Mar. 30, 2024
Business Acquisition [Line Items]
Goodwill	$ 2,437,790	$ 2,534,601

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Mar. 30, 2024
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization			$ 70,664	$ 61,103
Goodwill	$ 2,437,790		2,437,790		$ 2,534,601
Goodwill, Impairment Loss	(96,458)	$ (48,000)	(96,458)	$ (48,000)
Goodwill, Written off Related to Sale of Business Unit			1,000
Goodwill, Accumulated impairment losses and write-offs	999,900		999,900		903,400
Accumulated Amortization	558,718		558,718		559,810
Gross Carrying Amount	1,004,433		1,004,433		1,069,193
Technology licenses
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	74,625		74,625		54,869
Accumulated Amortization	17,052		17,052		6,525
Trade Names
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	700		700		1,610
Accumulated Amortization	146		146		939
Developed Technology
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	819,450		819,450		903,089
Accumulated Amortization	465,031		465,031		484,347
Customer Relationships
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	100,040		100,040		100,040
Accumulated Amortization	76,489		76,489		67,999
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD	9,618		9,618		9,585
HPA
Goodwill and Intangible Assets [Line Items]
Goodwill	421,731		421,731		517,542
Goodwill, Impairment Loss			(96,458)
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent	0		0
CSG
Goodwill and Intangible Assets [Line Items]
Goodwill	300,099		300,099		300,299
Goodwill, Impairment Loss			0
Goodwill, Written off Related to Sale of Business Unit			200
ACG
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 1,715,960		1,715,960		$ 1,716,760
Goodwill, Impairment Loss			0
Goodwill, Written off Related to Sale of Business Unit			800
Anokiwave
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments			647
Anokiwave | HPA
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments			647
Anokiwave | CSG
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments			0
Anokiwave | ACG
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments			$ 0

Investments and Fair Value of_2

Investments and Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Sep. 28, 2024	Mar. 30, 2024
Mutual Fund
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Deferred Compensation Plan Assets	$ 58.5	$ 52.3

Debt (Details)

Debt (Details) - USD ($)		3 Months Ended		6 Months Ended
	Apr. 23, 2024	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Mar. 30, 2024	Dec. 14, 2021	Sep. 29, 2020	Jun. 11, 2020	Dec. 20, 2019	Sep. 30, 2019
Debt Instrument [Line Items]
Long-term debt		$ 1,549,244,000		$ 1,549,244,000		$ 1,549,272,000
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net		(1,040,000)		(1,040,000)		(1,726,000)
Debt, Long-Term and Short-Term, Combined Amount		1,961,423,000		1,961,423,000		1,988,012,000
Long-term Debt, Current Maturities		(412,179,000)		(412,179,000)		(438,740,000)
Interest Expense, Borrowings		24,300,000	$ 17,900,000	42,000,000	$ 36,100,000
Interest Costs Capitalized		1,700,000	800,000	2,300,000	1,700,000
Interest expense		22,594,000	$ 17,121,000	39,688,000	34,382,000
4.375% senior notes due 2029
Debt Instrument [Line Items]
Debt Instrument, Face Amount		850,000,000		850,000,000		850,000,000			$ 300,000,000	$ 200,000,000	$ 350,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				18,600,000	18,600,000
Debt Instrument, Interest Rate, Stated Percentage											4.375%
4.375% senior notes due 2029 | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		824,500,000		824,500,000		797,600,000
3.375% Senior Notes due 2031 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount		700,000,000		700,000,000		700,000,000		$ 700,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				11,800,000	0
Debt Instrument, Interest Rate, Stated Percentage								3.375%
3.375% Senior Notes due 2031 [Member] | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		626,800,000		626,800,000		603,800,000
Senior Notes Due 2024 1.750%
Debt Instrument [Line Items]
Debt Instrument, Face Amount		412,463,000		412,463,000		439,738,000	$ 500,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				3,600,000	$ 4,400,000
Debt Instrument, Interest Rate, Stated Percentage							1.75%
Debt Instrument, Repurchased Face Amount		27,300,000		27,300,000		60,300,000
Gain (Loss) on Repurchase of Debt Instrument		600,000
Senior Notes Due 2024 1.750% | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		409,000,000		409,000,000		$ 426,900,000
Credit Agreement | Federal Funds Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Agreement | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1%
Credit Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.10%
Credit Agreement | Maximum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.75%
Credit Agreement | Maximum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.75%
Credit Agreement | Maximum [Member] | Loan Purchase Commitments
Debt Instrument [Line Items]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.275%
Credit Agreement | Minimum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0%
Credit Agreement | Minimum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1%
Credit Agreement | Minimum [Member] | Loan Purchase Commitments
Debt Instrument [Line Items]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.125%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Proceeds from Lines of Credit		$ 0		$ 0
Revolving Credit Facility [Member] | Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 325,000,000
Revolving Credit Facility [Member] | Credit Agreement | Standby Letters of Credit [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	25,000,000
Revolving Credit Facility [Member] | Credit Agreement | Swing line advances
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 10,000,000

Stock Repurchases (Details)

Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Nov. 02, 2022
Class of Stock [Line Items]
Stock Repurchased During Period, Shares	0.7	1	2	2
Stock Repurchased During Period, Value	$ 81,746	$ 100,554	$ 207,471	$ 201,166
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 1,098,700		$ 1,098,700
Document Period End Date			Sep. 28, 2024
November 2, 2022 Program
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount					$ 2,000,000

Revenue (Details)

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Disaggregation of Revenue
Revenues	$ 1,046,509	$ 1,103,493	$ 1,933,180	$ 1,754,657
China
Disaggregation of Revenue
Revenues	151,763	189,900	348,197	340,706
Taiwan
Disaggregation of Revenue
Revenues	102,298	66,162	194,852	132,018
United States
Disaggregation of Revenue
Revenues	656,610	699,288	1,104,066	1,014,571
Europe
Disaggregation of Revenue
Revenues	22,653	28,748	40,844	56,633
Other Asia
Disaggregation of Revenue
Revenues	$ 113,185	$ 119,395	$ 245,221	$ 210,729

Restructuring and Related Act_3

Restructuring and Related Activities (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended	24 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 28, 2024	Mar. 30, 2024
Restructuring
Goodwill, Impairment Loss	$ 96,458	$ 48,000	$ 96,458	$ 48,000
Impairment of Intangible Assets, Finite-Lived	$ 16,600
Schedule of restructuring activity			The following table summarizes charges resulting from the 2025 Restructuring Initiative (in thousands): Three Months Ended September 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ — $ — $ 2,649 $ 2,649 Asset impairment costs 13,660 96,458 16,766 126,884 Total $ 13,660 $ 96,458 $ 19,415 $ 129,533 Six Months Ended September 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ — $ — $ 3,048 $ 3,048 Asset impairment costs 13,660 96,458 16,766 126,884 Total $ 13,660 $ 96,458 $ 19,814 $ 129,932 The following table summarizes charges resulting from the 2024 Restructuring Initiative (in thousands): Three Months Ended September 28, 2024 Six Months Ended September 28, 2024 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ — $ 643 $ 643 $ — $ 3,995 $ 3,995 Asset impairment costs (adjustments) (1) 1,754 (2,358) (604) 1,754 5,718 7,472 One-time employee termination benefits — 386 386 — 5,712 5,712 Total $ 1,754 $ (1,329) $ 425 $ 1,754 $ 15,425 $ 17,179 (1) Refer to Note 4 for additional information. The following tables summarize the charges resulting from the 2023 Restructuring Initiatives (in thousands): Three Months Ended September 28, 2024 Six Months Ended September 28, 2024 Other Operating Expense Other Operating Expense Contract termination and other costs $ 92 $ 186 One-time employee termination benefits — 321 Total $ 92 $ 507 Three Months Ended September 30, 2023 Six Months Ended September 30, 2023 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 2,482 $ 1,328 $ 3,810 $ 19,278 $ 2,757 $ 22,035 Asset impairment costs — 3,646 3,646 2,159 4,286 6,445 One-time employee termination benefits — 962 962 — 2,674 2,674 Total $ 2,482 $ 5,936 $ 8,418 $ 21,437 $ 9,717 $ 31,154
Restructuring Liabilities Rollforward	The following table summarizes the liability activity related to the 2024 Restructuring Initiative for the six months ended September 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 7,432 $ 4,080 $ 11,512 Costs incurred and charged to expense 5,712 3,995 9,707 Cash payments (12,512) (7,355) (19,867) Accrued restructuring balance as of September 28, 2024 $ 632 $ 720 $ 1,352 The following table summarizes the liability activity related to the 2023 Restructuring Initiatives for the six months ended September 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 347 $ 9,308 $ 9,655 Costs incurred and charged to expense 321 186 507 Cash payments (668) (9,402) (10,070) Accrued restructuring balance as of September 28, 2024 $ — $ 92 $ 92		The following table summarizes the liability activity related to the 2025 Restructuring Initiative for the six months ended September 28, 2024 (in thousands): Contract Termination and Other Costs Accrued restructuring balance as of March 30, 2024 $ — Costs incurred and charged to expense 3,048 Cash payments (3,048) Accrued restructuring balance as of September 28, 2024 $ —
fiscal year 2023 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 92	8,418	$ 507	31,154
Restructuring
Restructuring Charges	92	8,418	507	31,154
Payments for Restructuring			(10,070)
Restructuring Reserve	92		92		$ 92	$ 92	$ 9,655
Restructuring and Related Cost, Incurred Cost			507
fiscal year 2023 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	0	962	321	2,674		5,900
Restructuring
Restructuring Charges	0	962	321	2,674		5,900
Payments for Restructuring			(668)
Restructuring Reserve	0		0		0	0	347
Restructuring and Related Cost, Incurred Cost			321
fiscal year 2023 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges		3,646		6,445		99,900
Restructuring
Restructuring Charges		3,646		6,445		99,900
fiscal year 2023 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	92	3,810	186	22,035		46,200
Restructuring
Restructuring Charges	92	3,810	186	22,035		46,200
Payments for Restructuring			(9,402)
Restructuring Reserve	92		92		92	92	9,308
Restructuring and Related Cost, Incurred Cost			186
fiscal year 2023 initiative [Member] | Impaired goodwill
Restructuring and Related Activities [Abstract]
Restructuring Charges						12,400
Restructuring
Restructuring Charges						12,400
Fiscal year 2024 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges	425		17,179
Restructuring
Restructuring Charges	425		17,179
Payments for Restructuring			(19,867)
Restructuring Reserve	1,352		1,352		1,352	1,352	11,512
Restructuring and Related Cost, Incurred Cost			9,707
Fiscal year 2024 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	386		5,712		14,600
Restructuring
Restructuring Charges	386		5,712		14,600
Payments for Restructuring			(12,512)
Restructuring Reserve	632		632		632	632	7,432
Restructuring and Related Cost, Incurred Cost			5,712
Fiscal year 2024 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	(604)		7,472		44,400
Restructuring
Restructuring Charges	(604)		7,472		44,400
Fiscal year 2024 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	643		3,995		11,200
Restructuring
Restructuring Charges	643		3,995		11,200
Payments for Restructuring			(7,355)
Restructuring Reserve	720		720		720	720	4,080
Restructuring and Related Cost, Incurred Cost			3,995
Fiscal year 2025 initiative
Restructuring and Related Activities [Abstract]
Restructuring Charges	129,533		129,932
Restructuring
Restructuring Charges	129,533		129,932
Fiscal year 2025 initiative | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	126,884		126,884
Restructuring
Restructuring Charges	126,884		126,884
Fiscal year 2025 initiative | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	2,649		3,048
Restructuring
Restructuring Charges	2,649		3,048
Payments for Restructuring			(3,048)
Restructuring Reserve	$ 0		0		$ 0	$ 0	$ 0
Restructuring and Related Cost, Incurred Cost			$ 3,048
Other operating expense | fiscal year 2023 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges		5,936		9,717
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses		Operating Expenses
Restructuring
Restructuring Charges		5,936		9,717
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses		Operating Expenses
Other operating expense | fiscal year 2023 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges		962		2,674
Restructuring
Restructuring Charges		962		2,674
Other operating expense | fiscal year 2023 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges		3,646		4,286
Restructuring
Restructuring Charges		3,646		4,286
Other operating expense | fiscal year 2023 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges		1,328		2,757
Restructuring
Restructuring Charges		1,328		2,757
Other operating expense | Fiscal year 2024 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ (1,329)		$ 15,425
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses		Operating Expenses
Restructuring
Restructuring Charges	$ (1,329)		$ 15,425
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses		Operating Expenses
Other operating expense | Fiscal year 2024 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 386		$ 5,712
Restructuring
Restructuring Charges	386		5,712
Other operating expense | Fiscal year 2024 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	(2,358)		5,718
Restructuring
Restructuring Charges	(2,358)		5,718
Other operating expense | Fiscal year 2024 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	643		3,995
Restructuring
Restructuring Charges	643		3,995
Other operating expense | Fiscal year 2025 initiative
Restructuring and Related Activities [Abstract]
Restructuring Charges	19,415		19,814
Restructuring
Restructuring Charges	19,415		19,814
Other operating expense | Fiscal year 2025 initiative | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	16,766		16,766
Restructuring
Restructuring Charges	16,766		16,766
Other operating expense | Fiscal year 2025 initiative | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	2,649		3,048
Restructuring
Restructuring Charges	2,649		3,048
Cost of goods sold | fiscal year 2023 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges		2,482		21,437
Restructuring
Restructuring Charges		2,482		21,437
Cost of goods sold | fiscal year 2023 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges		0		0
Restructuring
Restructuring Charges		0		0
Cost of goods sold | fiscal year 2023 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges		0		2,159
Restructuring
Restructuring Charges		0		2,159
Cost of goods sold | fiscal year 2023 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges		2,482		19,278
Restructuring
Restructuring Charges		$ 2,482		$ 19,278
Cost of goods sold | Fiscal year 2024 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 1,754		$ 1,754
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses		Cost of goods sold
Restructuring
Restructuring Charges	$ 1,754		$ 1,754
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses		Cost of goods sold
Cost of goods sold | Fiscal year 2024 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 0		$ 0
Restructuring
Restructuring Charges	0		0
Cost of goods sold | Fiscal year 2024 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	1,754		1,754
Restructuring
Restructuring Charges	1,754		1,754
Cost of goods sold | Fiscal year 2024 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	0		0
Restructuring
Restructuring Charges	0		0
Cost of goods sold | Fiscal year 2025 initiative
Restructuring and Related Activities [Abstract]
Restructuring Charges	13,660		13,660
Restructuring
Restructuring Charges	13,660		13,660
Cost of goods sold | Fiscal year 2025 initiative | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	13,660		13,660
Restructuring
Restructuring Charges	13,660		13,660
Cost of goods sold | Fiscal year 2025 initiative | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	0		0
Restructuring
Restructuring Charges	0		0
Impaired goodwill | Fiscal year 2025 initiative
Restructuring and Related Activities [Abstract]
Restructuring Charges	96,458		96,458
Restructuring
Restructuring Charges	96,458		96,458
Impaired goodwill | Fiscal year 2025 initiative | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	96,458		96,458
Restructuring
Restructuring Charges	96,458		96,458
Impaired goodwill | Fiscal year 2025 initiative | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	0		0
Restructuring
Restructuring Charges	$ 0		$ 0

Operating Segment Information_2

Operating Segment Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 28, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 28, 2024 USD ($)	Sep. 30, 2023 USD ($)
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Document Period End Date			Sep. 28, 2024
Summary of details of reportable segments
Revenues	$ 1,046,509	$ 1,103,493	$ 1,933,180	$ 1,754,657
Income from operations:
Operating income	9,675	151,428	14,281	103,292
Interest expense	22,594	17,121	39,688	34,382
Other income (expense), net	15,422	5,211	27,187	18,927
Income before income taxes	2,503	139,518	1,780	87,837
Stock-based compensation expense			(80,547)	(77,498)
Amortization of intangible assets			(70,664)	(61,103)
Goodwill, Impairment Loss	$ (96,458)	(48,000)	(96,458)	(48,000)
Number of Reportable Segments	3
HPA
Income from operations:
Goodwill, Impairment Loss			(96,458)
CSG
Income from operations:
Goodwill, Impairment Loss			0
ACG
Income from operations:
Goodwill, Impairment Loss			0
Operating Segments | HPA
Summary of details of reportable segments
Revenues	$ 148,251	149,804	277,719	289,496
Income from operations:
Operating income	13,066	25,446	17,947	49,410
Operating Segments | CSG
Summary of details of reportable segments
Revenues	146,822	103,622	261,675	202,885
Income from operations:
Operating income	(8,974)	(27,725)	(28,475)	(47,886)
Operating Segments | ACG
Summary of details of reportable segments
Revenues	751,436	850,067	1,393,786	1,262,276
Income from operations:
Operating income	215,057	284,805	331,506	329,803
All other
Income from operations:
Operating income	(209,474)	(131,098)	(306,697)	(228,035)
Stock-based compensation expense	(38,181)	(39,053)	(80,547)	(77,498)
Amortization of intangible assets	(29,482)	(29,963)	(59,956)	(60,835)
Restructuring Charges	(34,396)	(8,418)	(53,970)	(31,154)
Acquisition and integration-related costs	(1,211)	(852)	(3,793)	(2,047)
Other	$ (9,746)	$ (4,812)	$ (11,973)	$ (8,501)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income tax benefit	$ 19,938	$ 42,057	$ 18,801	$ 33,956
Effective tax rate	796.50%	30.10%	1,056.40%	38.70%
Effective Income Tax Rate Reconciliation, Disposition of Business, Amount	$ 4,300		$ 200
Effective Income Tax Rate Reconciliation, Foreign Currency Gain or Loss		$ 5,600		$ 5,500

Net Income Per Share (Details)

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Document Period End Date			Sep. 28, 2024
Numerator:
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ (17,435)	$ 97,461	$ (17,021)	$ 53,881
EPS Line Items
Denominator for basic net income (loss) per share — weighted average shares	94,886	97,945	95,116	98,167
Stock-based awards	0	645	0	725
Denominator for diluted net income (loss) per share — adjusted weighted average shares and assumed conversions	94,886	98,590	95,116	98,892
Basic net income (loss) per share (in dollars per share)	$ (0.18)	$ 1	$ (0.18)	$ 0.55
Diluted net income (loss) per share (in dollars per share)	$ (0.18)	$ 0.99	$ (0.18)	$ 0.54